Related Experiment Video
Updated: Jun 27, 2026

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
Published on: February 13, 2026
Interferon alpha increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent
Teresa Díaz-Sanjuán1, Inmaculada García-Ruiz, Cristina Rodríguez-Juan
1Department of Gastroenterology, Research Center, Hospital Universitario 12 de Octubre, Avenida de Andalucia, s/n. Madrid, Spain.
Background/Aims:
To determine the effects of IFNalpha on MMP-13 gene expression in primary culture of hepatic stellate cells.
Methods:
We measured MMP-13 mRNA, MMP-13 protein, MMP-13 luciferase activity, binding of AP1 and PEA3 to DNA, and binding of PEA3 to Jak1 and Stat1.
Results:
IFNalpha increased MMP-13 mRNA, MMP-13 protein, and luciferase activity in cells transfected either with a luciferase plasmid driven by the MMP-13 promoter or with the same plasmid in which the AP1 binding site has been mutated. IFNalpha induced the binding of nuclear proteins to a radiolabeled PEA3 probe, but not to a AP1 probe. Supershift assays demonstrated that PEA3 and Stat1 are implicated in the formation of this complex. Immunoprecipitation assays showed that PEA3 interacts physically with Stat1 and that IFNalpha treatment increases this interaction. Downregulation of PEA3 or JAK1 with appropriated siRNAs or mutation of the PEA3 binding site in the MMP-13 promoter abrogated the effects of IFNalpha on MMP-13 gene expression. Finally, IFNalpha induced the binding of PEA3 to JAK1, as well as PEA3 tyrosine and serine phosphorylation.
Conclusions:
IFNalpha determines the binding of PEA3 to JAK1 and its tyrosine phosphorylation. Activated PEA3 binds to MMP-13 promoter and activates its expression.
Insights
Interferon-alpha (IFNalpha) activates matrix metalloproteinase-13 (MMP-13) gene expression in hepatic stellate cells by promoting PEA3 binding to the MMP-13 promoter, involving JAK1 and STAT1 signaling pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Hepatic stellate cells (HSCs) play a crucial role in liver fibrosis.
- Matrix metalloproteinase-13 (MMP-13) is implicated in extracellular matrix remodeling.
- Interferon-alpha (IFNalpha) is a cytokine with diverse biological functions.
Purpose of the Study:
- To investigate the effect of IFNalpha on MMP-13 gene expression in primary HSCs.
- To elucidate the molecular mechanisms underlying IFNalpha-mediated MMP-13 regulation.
Main Methods:
- Measurement of MMP-13 mRNA and protein levels.
- Luciferase reporter assays using MMP-13 promoter constructs.
- Electrophoretic mobility shift assays (EMSAs) to assess transcription factor binding.
- Co-immunoprecipitation and Western blot analyses to study protein interactions and phosphorylation.
Main Results:
- IFNalpha significantly upregulated MMP-13 mRNA, protein, and promoter activity.
- IFNalpha induced the binding of PEA3 transcription factor to the MMP-13 promoter.
- PEA3 physically interacted with JAK1 and STAT1, and IFNalpha enhanced this interaction and PEA3 phosphorylation.
- Downregulation of PEA3 or JAK1 abolished IFNalpha's effect on MMP-13 expression.
Conclusions:
- IFNalpha activates MMP-13 gene expression in HSCs.
- This activation is mediated by the recruitment of PEA3 to the MMP-13 promoter.
- The JAK1-STAT1 signaling pathway is essential for IFNalpha-induced PEA3 activation and subsequent MMP-13 expression.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
Cell Specific Gene Expression

